Literature DB >> 26478133

The role of surgery in grade II/III oligodendroglial tumors.

Niklas Thon1, Friedrich-Wilhelm Kreth1, Joerg-Christian Tonn1.   

Abstract

Supratentorial gliomas WHO grade II and III with an oligodendroglial phenotype are highly infiltrative lesions that preferentially originate in lobar location. Open tumor resection represents one of the mainstays of management as beneficial decompressive effects for large space-occupying lesions and oncologically relevant cytoreductive effects from complete resection can be expected. In patients not eligible for safe tumor resection meticulous histological and molecular-genetic evaluation can be obtained from advanced stereotactic biopsy techniques. In this perspective, important aspects of open tumor surgery and stereotactic biopsy are discussed within the context of diagnosis, prognosis and treatment of oligodendrogliomas and oligoastrocytomas WHO grade II and III. Practical considerations are provided in order to integrate the place of surgery into an increasingly personalized management concept. For highly selected patients interstitial brachytherapy is introduced as an alternative surgically performed treatment option.

Entities:  

Keywords:  astrocytoma; brachytherapy; eloquent location; extent of resection; high-grade glioma; imaging; iodine-125 seeds; low-grade glioma; microsurgery; molecular-genetic markers; oligoastrocytoma; oligodendroglioma; prognosis; resectability; stereotactic biopsy

Mesh:

Year:  2015        PMID: 26478133      PMCID: PMC6082329          DOI: 10.2217/cns.15.26

Source DB:  PubMed          Journal:  CNS Oncol        ISSN: 2045-0907


  66 in total

1.  Detection of intratumoral calcification in oligodendrogliomas by susceptibility-weighted MR imaging.

Authors:  M Zulfiqar; N Dumrongpisutikul; J Intrapiromkul; D M Yousem
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-19       Impact factor: 3.825

Review 2.  Molecular imaging of gliomas with PET: opportunities and limitations.

Authors:  Christian la Fougère; Bogdana Suchorska; Peter Bartenstein; Friedrich-Wilhelm Kreth; Jörg-Christian Tonn
Journal:  Neuro Oncol       Date:  2011-07-13       Impact factor: 12.300

3.  Updated therapeutic strategy for adult low-grade glioma stratified by resection and tumor subtype.

Authors:  Masayuki Nitta; Yoshihiro Muragaki; Takashi Maruyama; Hiroshi Iseki; Soko Ikuta; Yoshiyuki Konishi; Taichi Saito; Manabu Tamura; Michael Chernov; Atsushi Watanabe; Saori Okamoto; Katsuya Maebayashi; Norio Mitsuhashi; Yoshikazu Okada
Journal:  Neurol Med Chir (Tokyo)       Date:  2013       Impact factor: 1.742

4.  Role of perfusion-weighted imaging at 3T in the histopathological differentiation between astrocytic and oligodendroglial tumors.

Authors:  Taiichi Saito; Fumiyuki Yamasaki; Yoshinori Kajiwara; Nobukazu Abe; Yuji Akiyama; Takako Kakuda; Yukio Takeshima; Kazuhiko Sugiyama; Yoshikazu Okada; Kaoru Kurisu
Journal:  Eur J Radiol       Date:  2011-05-04       Impact factor: 3.528

5.  Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article.

Authors:  Tamara Ius; Miriam Isola; Riccardo Budai; Giada Pauletto; Barbara Tomasino; Luciano Fadiga; Miran Skrap
Journal:  J Neurosurg       Date:  2012-10-05       Impact factor: 5.115

6.  Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

Authors:  Gregory Cairncross; Meihua Wang; Edward Shaw; Robert Jenkins; David Brachman; Jan Buckner; Karen Fink; Luis Souhami; Normand Laperriere; Walter Curran; Minesh Mehta
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

7.  Dynamic 18F-FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses.

Authors:  Niklas Thon; Mathias Kunz; Lena Lemke; Nathalie L Jansen; Sabina Eigenbrod; Simone Kreth; Jürgen Lutz; Rupert Egensperger; Armin Giese; Jochen Herms; Michael Weller; Hans Kretzschmar; Jörg-Christian Tonn; Christian la Fougère; Friedrich-Wilhelm Kreth
Journal:  Int J Cancer       Date:  2014-11-03       Impact factor: 7.396

Review 8.  Functional magnetic resonance imaging for neurosurgical planning in neurooncology.

Authors:  Erik-Jan Vlieger; Charles B Majoie; Sieger Leenstra; Gerard J Den Heeten
Journal:  Eur Radiol       Date:  2004-05-18       Impact factor: 5.315

9.  Novel molecular stereotactic biopsy procedures reveal intratumoral homogeneity of loss of heterozygosity of 1p/19q and TP53 mutations in World Health Organization grade II gliomas.

Authors:  Niklas Thon; Sabina Eigenbrod; Eva M Grasbon-Frodl; Michael Ruiter; Jan H Mehrkens; Simone Kreth; Jörg C Tonn; Hans A Kretzschmar; Friedrich W Kreth
Journal:  J Neuropathol Exp Neurol       Date:  2009-11       Impact factor: 3.685

10.  Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?

Authors:  Nasuda Danchaivijitr; Adam D Waldman; Daniel J Tozer; Christopher E Benton; Gisele Brasil Caseiras; Paul S Tofts; Jeremy H Rees; H Rolf Jäger
Journal:  Radiology       Date:  2008-04       Impact factor: 11.105

View more
  4 in total

1.  Extent of resection and survival for oligodendroglioma: a U.S. population-based study.

Authors:  Connor J Kinslow; Andrew L A Garton; Ali I Rae; Logan P Marcus; Christopher M Adams; Guy M McKhann; Michael B Sisti; E Sander Connolly; Jeffrey N Bruce; Alfred I Neugut; Adam M Sonabend; Peter Canoll; Simon K Cheng; Tony J C Wang
Journal:  J Neurooncol       Date:  2019-08-12       Impact factor: 4.130

2.  Extent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular Subtype.

Authors:  S H Patel; A G Bansal; E B Young; P P Batchala; J T Patrie; M B Lopes; R Jain; C E Fadul; D Schiff
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-27       Impact factor: 3.825

3.  Weighted gene correlation network analysis identifies microenvironment-related genes signature as prognostic candidate for Grade II/III glioma.

Authors:  Yong Li; Gang Deng; Huikai Zhang; Yangzhi Qi; Lun Gao; Yinqiu Tan; Ping Hu; Yixuan Wang; Baohui Liu; Qianxue Chen
Journal:  Aging (Albany NY)       Date:  2020-11-07       Impact factor: 5.682

4.  Current and Future Frontiers of Molecularly Defined Oligodendrogliomas.

Authors:  Jordina Rincon-Torroella; Maureen Rakovec; Josh Materi; Divyaansh Raj; Tito Vivas-Buitrago; Abel Ferres; William Reyes Serpa; Kristin J Redmond; Matthias Holdhoff; Chetan Bettegowda; José Juan González Sánchez
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.